Flexion Therapeutics

📍 Burlington, United States🗓 Founded 2007👥 45 employees💰 Last funded Dec 2012
Biotechnology Research🌐 flexiontherapeutics.com
Website LinkedIn
Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the discovery, development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Flexion is based in Burlington, Massachusetts. View our terms of use: https://flexiontherapeutics.com/terms-of-use/
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2007
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Flexion Therapeutics?
Flexion Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Flexion Therapeutics last raise funding?
The most recent investment in Flexion Therapeutics recorded on gritt.io was in December 2012.
When was Flexion Therapeutics founded?
Flexion Therapeutics was founded in 2007.
What industry is Flexion Therapeutics in?
Flexion Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Flexion Therapeutics based?
Flexion Therapeutics is headquartered in Burlington, United States.